Jan 8, 2018 by Brian FeroldiWhy Exact Sciences Is Tumbling TodayThis is what happens when expectations get out of control.
Jan 8, 2018 by Brian Feroldi, Neha Chamaria, and Reuben Gregg Brewer3 Top Value Stocks to Buy in JanuaryAre you looking for a bargain in today's pricy market? Start your search with these three stocks.
Jan 6, 2018 by Brian Feroldi3 Scorching-Hot Healthcare Stocks -- Are They Buys?These three companies gained at least 400% in 2017. Can the good times continue?
Jan 5, 2018 by Brian FeroldiWhy OraSure Technologies, Inc. Rallied 10.8% in DecemberShares bounced back from their drubbing in November.
Jan 5, 2018 by Brian FeroldiThese Two Updates Caused MannKind's Stock to Plunge 25.9% in December The hits keep on coming for the biotech.
Jan 4, 2018 by Brian FeroldiWhy TransEnterix Dropped 17.5% in DecemberEven a non-dilutive capital raise wasn't enough to get investors excited.
Jan 4, 2018 by Brian FeroldiIs This Why Exact Sciences Fell 11.7% in December?The momentum stock stalled after an SEC filing revealed that insiders have been cashing in some of their chips.
Jan 4, 2018 by Brian FeroldiThis News Explains Why DexCom Is Dropping TodayShares slide after news breaks that a competitor's product nabs an important reimbursement win.
Jan 4, 2018 by Brian FeroldiWhy Mazor Robotics Fell 10.8% in DecemberShares fall by double-digits during a quiet month for the robotic surgery upstart. Is there something to worry about, or is the pullback just market noise?
Jan 2, 2018 by Brian FeroldiWhy Inovio Pharmaceuticals Inc. Is Soaring TodayShares jump after news breaks that the company has amended the terms of one of its partnership deals.
Dec 31, 2017 by Brian FeroldiTransEnterix's Piggy Bank Gets Fatter, but Are Shares Finally a Buy?Management just padded its wallet by selling off its SurgiBot system, but what's next for the robotic surgery upstart?
Dec 26, 2017 by Brian FeroldiThe 1 Stock I'd Buy Right NowThis software-as-a-service provider is profitable and growing fast, which makes today's price a bargain.
Dec 26, 2017 by Brian Feroldi, Travis Hoium, and Leo Sun3 Top Stocks Wall Street Is OverlookingJust because investors are ignoring these three gems doesn't mean that you have to.
Dec 23, 2017 by Brian FeroldiThe Best High-Yield Dividend Stocks of 2017These three income stocks served up huge gains in 2017.
Dec 23, 2017 by Brian Feroldi, Jeremy Bowman, and Neha ChamariaThese 3 Stocks Grew 30% in 2017, and They Aren't Slowing DownDon't let surging share prices fool you into thinking that these three gems can't move higher.
Dec 21, 2017 by Brian Feroldi, Jeremy Bowman, and Neha Chamaria3 Stocks That Could Put Amazon's Returns to ShameLooking for stocks with lots of upside potential? These three high-growth companies have you covered.
Dec 20, 2017 by Brian Feroldi3 Top Generic Drug Stocks to Consider Buying NowWant to cash in on the pharmaceutical boom? Generic drugs add to the arguments for giving Pfizer, Novartis and Mylan a closer look.
Dec 20, 2017 by Brian Feroldi, Travis Hoium, and Leo Sun3 Dividend Stocks With Better Yields Than Procter & GambleWant to do better than a 3% yield? Consider these three dividend gems.
Dec 19, 2017 by Brian Feroldi3 Top Pharmaceutical Dividend Stocks to Buy NowLooking for income from the pharmaceutical industry? Start with these three companies.
Dec 19, 2017 by Brian Feroldi3 Wonderful Debt-Free Companies to Buy NowThese high-quality businesses avoid debt like the plague.
